Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation-Reference-Cited by-同舟云学术

Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation

Published:2021-01-02 Issue:5 Volume:108 Page:587-594
ISSN:0171-967X
Container-title:Calcified Tissue International
language:en
Short-container-title:Calcif Tissue Int

Author:

Anastasilakis Athanasios D.^ORCID,Polyzos Stergios A.^ORCID,Yavropoulou Maria P.^ORCID,Appelman-Dijkstra Natasha M.^ORCID,Ntenti Charikleia,Mandanas Stylianos,Papatheodorou Athanasios,Makras Polyzois^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00223-020-00785-1.pdf

Reference19 articles.

1. Lamy O, Stoll D, Aubry-Rozier B, Rodriguez EG (2019) Stopping denosumab. Curr Osteoporos Rep 17:8–15

2. Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O (2017) Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases. J Bone Miner Res 32:1291–1296

3. Bone HG, Wagman RB, Brandi ML et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5:513–523

4. Cummings SR, Ferrari S, Eastell R et al (2018) Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res 33:190–198

5. McClung MR, Wagman RB, Miller PD, Wang A, Lewiecki EM (2017) Observations following discontinuation of long-term denosumab therapy. Osteoporos Int 28:1723–1732

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Bisphosphonates Prior to Denosumab Treatment on Rebound Fractures: A Mini Review;Journal of Bone Metabolism;2022-11-30

2. Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature;Endocrinology and Metabolism;2022-04-30

3. The effect of osteoporosis treatment on bone mass;Best Practice & Research Clinical Endocrinology & Metabolism;2022-03

4. Long-term consequences of osteoporosis therapy with denosumab;Archives of Endocrinology and Metabolism;2022

5. The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation;The Journal of Clinical Endocrinology & Metabolism;2021-05-12